Vensana Capital, a venture capital and growth equity investment firm, led a $20m round in Artelon, a privately held medical device company. "Artelon has focused deeply on surgical solutions for ankle instability, a large and underserved market. Ankle sprains are the number one reason for emergency room visits in the United States, and up to 20 percent of those patients will develop chronic instability after these injuries. While traditional surgical procedures can mitigate ankle instability, patients endure a long recovery period and can still have residual pain or instability over the long term," Aaron Smith, Artelon CEO.